LobbyingPediatrix Medical Group lobbying by quarter
Pediatrix Medical Group MD's latest lobbying report covers Q2 2026, at $90K. The four quarters Q4 2025–Q3 2026 total $370K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Pediatrix Medical GroupMD
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $370K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $350K | 2 |
| Q1 2023 | $350K | 2 |
| Q2 2023 | $270K | 2 |
| Q3 2023 | $280K | 2 |
| Q4 2023 | $270K | 2 |
| Q1 2024 | $270K | 2 |
| Q2 2024 | $140K | 2 |
| Q3 2024 | $140K | 2 |
| Q4 2024 | $140K | 2 |
| Q1 2025 | $140K | 2 |
| Q2 2025 | $200K | 3 |
| Q3 2025 | $318K | 3 |
| Q4 2025 | $190K | 2 |
| Q1 2026 | $90K | 1 |
| Q2 2026 | $90K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$2.2M · 22 reports
- Medicare and Medicaid$260K · 7 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE20 reports
- HOUSE OF REPRESENTATIVES16 reports
- Centers For Medicare and Medicaid Services (CMS)10 reports
- Health & Human Services, Dept of (HHS)8 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-housePediatrix Medical Group | $2.2M | 13 quarters |
| Avenue Solutions | $580K | 12 quarters |
| Carmen Group | $420K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MATTHEW FUENTES | LA - Senate Democratic Minority Leader Sen. Chuck Schumer; LA -Senate Democratic Majority Leader Sen. Chuck Schumer; Legislative Aide - Sen. Chuck Schumer; Research Assistant - Senate Finance Committee (Sen. Ron Wyden) | Q2 2025 |
| BARCLAY GANG | None | Q3 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Carmen Group | $90K |
| 04/20for Q1 | Carmen Group | $90K |
| 01/20for Q4 2025 | Carmen Group | $90K |
| 01/20for Q4 2025 | In-house | $100K |
| 25/10/20for Q3 2025 | Avenue Solutions | $30K |
| 25/10/20for Q3 2025 | In-house | $168K |
| 25/10/20for Q3 2025 | Carmen Group | $120K |
| 25/07/21for Q2 2025 | Avenue Solutions | $50K |
| 25/07/21for Q2 2025 | In-house | $120K |
| 25/07/17for Q2 2025 | Carmen Group | $30K |
| 25/06/13for Q2 2025 | Carmen Group | Under $5,000 |
| 25/04/21for Q1 2025 | Avenue Solutions | $50K |
| 25/04/19for Q1 2025 | In-house | $90K |
| 25/01/21for Q4 2024 | Avenue Solutions | $50K |
| 25/01/21for Q4 2024 | In-house | $90K |
| 24/10/21for Q3 2024 | Avenue Solutions | $50K |
| 24/10/15for Q3 2024 | In-house | $90K |
| 24/07/22for Q2 2024 | Avenue Solutions | $50K |
| 24/07/20for Q2 2024 | In-house | $90K |
| 24/04/22for Q1 2024 | Avenue Solutions | $50K |